AU1665992A - Novel taurine-based pharmaceutical composition for administration by inhalation - Google Patents

Novel taurine-based pharmaceutical composition for administration by inhalation

Info

Publication number
AU1665992A
AU1665992A AU16659/92A AU1665992A AU1665992A AU 1665992 A AU1665992 A AU 1665992A AU 16659/92 A AU16659/92 A AU 16659/92A AU 1665992 A AU1665992 A AU 1665992A AU 1665992 A AU1665992 A AU 1665992A
Authority
AU
Australia
Prior art keywords
administration
taurine
inhalation
pharmaceutical composition
based pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU16659/92A
Other versions
AU656775B2 (en
Inventor
Jesus Covarrubias
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LABORATOIRE NATIVELLE SA
Original Assignee
Laboratoire Nativelle SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire Nativelle SA filed Critical Laboratoire Nativelle SA
Publication of AU1665992A publication Critical patent/AU1665992A/en
Application granted granted Critical
Publication of AU656775B2 publication Critical patent/AU656775B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Form of taurine administration giving rise to a novel therapeutic use. The pharmaceutical composition contains taurine or hypotaurine in combination with means for its administration by inhalation, especially in aerosol form, where the taurine concentration is between 5 g/1 and 50 g/1 of solvent. Application in the treatment of asthma and conditions affecting the respiratory tract.
AU16659/92A 1991-03-27 1992-03-27 Novel taurine-based pharmaceutical composition for administration by inhalation Ceased AU656775B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9103693 1991-03-27
FR9103693A FR2674434B1 (en) 1991-03-27 1991-03-27 NOVEL PHARMACEUTICAL COMPOSITION BASED ON TAURIN FOR INHALATION ADMINISTRATION.
PCT/FR1992/000282 WO1992017170A1 (en) 1991-03-27 1992-03-27 Novel taurine-based pharmaceutical composition for administration by inhalation

Publications (2)

Publication Number Publication Date
AU1665992A true AU1665992A (en) 1992-11-02
AU656775B2 AU656775B2 (en) 1995-02-16

Family

ID=9411170

Family Applications (1)

Application Number Title Priority Date Filing Date
AU16659/92A Ceased AU656775B2 (en) 1991-03-27 1992-03-27 Novel taurine-based pharmaceutical composition for administration by inhalation

Country Status (14)

Country Link
EP (1) EP0533896B1 (en)
JP (1) JPH06501954A (en)
KR (1) KR100196060B1 (en)
AT (1) ATE142874T1 (en)
AU (1) AU656775B2 (en)
BR (1) BR9204815A (en)
CA (1) CA2083825A1 (en)
DE (1) DE69213874T2 (en)
DK (1) DK0533896T3 (en)
ES (1) ES2093829T3 (en)
FR (1) FR2674434B1 (en)
GR (1) GR3022083T3 (en)
NO (1) NO301521B1 (en)
WO (1) WO1992017170A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2696080B1 (en) * 1992-09-30 1994-12-23 Jesus Covarrubias Cigarette filter for administration of taurine by inhalation.
JP4921662B2 (en) * 1999-07-02 2012-04-25 株式会社日本化学工業所 Aminoethanesulfonic acid-containing preparation
KR100368011B1 (en) * 2000-03-23 2003-01-14 조금호 An enteral solution fortified with taurine
FR2833839A1 (en) * 2001-12-21 2003-06-27 Rytek Use of pulmonary epithelial cell myosin contraction inhibitors for the treatment or prevention of respiratory disorders such as asthma, allergies, and chronic obstructive lung diseases.
FR2833840B1 (en) * 2001-12-21 2010-06-18 Rytek METHODS AND COMPOSITIONS FOR THE TREATMENT OF RESPIRATORY PATHOLOGIES
FR2879100B1 (en) 2004-12-09 2007-07-06 Lionel Bueno COMPOSITIONS FOR THE TREATMENT OF OCULAR SURFACE PATHOLOGIES AND RETINA
DE102007040615A1 (en) * 2007-08-27 2009-03-05 Bitop Ag Osmolyte for the treatment of allergic or viral respiratory diseases
DE102008039231A1 (en) 2008-08-22 2010-02-25 Bitop Ag Use of glucosylglycerol
GB201305813D0 (en) * 2013-03-28 2013-05-15 Vectura Ltd Compositions and methods

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1226897B (en) * 1987-09-18 1991-02-21 Richerche Di Schiena Snc Del D TAURINE DERIVATIVES, ITS PREPARATION AND RELATED PHARMACEUTICAL COMPOSITIONS
JPH0368549A (en) * 1989-08-07 1991-03-25 Yamanouchi Pharmaceut Co Ltd Taurine derivative and leukotriene antagonistic agent containing the same as active ingredient

Also Published As

Publication number Publication date
ATE142874T1 (en) 1996-10-15
WO1992017170A1 (en) 1992-10-15
NO301521B1 (en) 1997-11-10
NO924578L (en) 1992-11-26
BR9204815A (en) 1993-07-27
NO924578D0 (en) 1992-11-26
FR2674434A1 (en) 1992-10-02
EP0533896A1 (en) 1993-03-31
KR100196060B1 (en) 1999-06-15
DE69213874D1 (en) 1996-10-24
JPH06501954A (en) 1994-03-03
DK0533896T3 (en) 1997-02-17
AU656775B2 (en) 1995-02-16
GR3022083T3 (en) 1997-03-31
DE69213874T2 (en) 1997-04-03
ES2093829T3 (en) 1997-01-01
EP0533896B1 (en) 1996-09-18
CA2083825A1 (en) 1992-09-28
FR2674434B1 (en) 1993-06-18
KR930700088A (en) 1993-03-13

Similar Documents

Publication Publication Date Title
US5518998C1 (en) Therapeutic preparation for inhalation
DE69232462T2 (en) COMPOSITION CONTAINING FORMOTEROL AND BUDESONIDE
TW329387B (en) Pharmaceutical composition for treating airway passage and lung diseases comprising mometasone furoate
FI935464A0 (en) Chlorofluorolfria aerosolformulationer
AU2517792A (en) Pharmaceutical aerosol preparation and its use for treatment and prophylaxis of viral diseases
AU1665992A (en) Novel taurine-based pharmaceutical composition for administration by inhalation
CZ220396A3 (en) Process of treating a medicament to aerosol, the use of a gas mixture and a therapeutical preparation
UA7190A (en) Method for treating pyo-inflammatory processes in lungs
KR890003399A (en) Pharmacologically active compounds and uses

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired